Latest round: Growth. Chen Schor is the President and Chief Executive Officer of Adicet Bio, a clinical stage biotechnology company.
Chen Schor is the President and Chief Executive Officer of Adicet Bio, a clinical stage biotechnology company. Adicet Bio focuses on discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. The company recently reported its third-quarter 2025 financial results and announced positive preliminary data from its Phase 1 trial of ADI-001 for autoimmune diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library